DropXcell enables more effective and lower risk drug discovery by quantifying millions of antibodies’ function in key biological pathways.
$125K
ARR
$2M
Current Raise
375000%
Committed
$210K
Previous Round


Quantify function in disease for millions of antibodies
Design and optimize antibody libraries with AI for high throughput screening
Help early stage therapeutic companies find lead antibody candidates or tool molecules for low upfront cost
Click to read more

37 handpicked Stanford companies, hundreds in attendance

In the launchpad, TheAgentic will build our AI backend for therapeutic discovery at no risk and no upfront cost

Luke pitched to over 500 people at Plug and Play Tech Center as one of 10 invited speakers

Presented DropXcell for hundreds and an investor panel to win the $25k prize!